BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19138190)

  • 1. Is your knowledge up-to-date? Bisphosphonate-related osteonecrosis of the jaw.
    Barrow SY
    Int J Dent Hyg; 2008 Nov; 6(4):376-7. PubMed ID: 19138190
    [No Abstract]   [Full Text] [Related]  

  • 2. Exposed bone in the palate.
    Siegel MA; Migliorati CA; Velez I; Forrest M
    J Am Dent Assoc; 2007 Oct; 138(10):1341-3. PubMed ID: 17908847
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diphosphonate therapy and osteonecrosis of the jaw].
    Løkken P; Skoglund LA; Skjelbred P
    Tidsskr Nor Laegeforen; 2007 Aug; 127(15):1945-7. PubMed ID: 17700737
    [No Abstract]   [Full Text] [Related]  

  • 4. Bisphosphonate induced osteochemonecrosis of the jaw mimicking a tumour.
    Pancholi M; Edwards A; Langton S
    Br Dent J; 2007 Jul; 203(2):87-9. PubMed ID: 17660778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paget's disease and bisphosphonate-associated osteonecrosis of the jaws.
    Gueiros LA; Lopes MA; Leão JC
    J Oral Maxillofac Surg; 2008 Jun; 66(6):1319. PubMed ID: 18486809
    [No Abstract]   [Full Text] [Related]  

  • 6. A compounded diagnosis: maxillary osteochemonecrosis in the setting of low dose radiotherapy.
    Magliocca KR; Stavropoulos MF; Bhattacharyya I; Cohen DM
    J Oral Maxillofac Surg; 2009 May; 67(5):1138-40. PubMed ID: 19375031
    [No Abstract]   [Full Text] [Related]  

  • 7. Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.
    Grewal VS; Fayans EP
    Todays FDA; 2008 Aug; 20(8):38-41, 43-6. PubMed ID: 18767452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Maxillar osteonecrosis associated with bisphosphonate treatment and dental implants].
    Savoldelli C; Le Page F; Santini J; Scortecci G; Odin G
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):555-8. PubMed ID: 17631371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteonecrosis of the jaw secondary to oral alendronate: Report of three cases].
    Bocanegra-Pérez S; Vicente-Barrero M; Sosa-Henríquez M; Gebaguer Blanco A; Knezevic M; Castellano-Navarro JM
    Rev Med Chil; 2009 Feb; 137(2):275-9. PubMed ID: 19543652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonate-induced osteonecrosis of the jaws.
    Throndson RR; Healy SM; Zwickey MR
    Tex Dent J; 2005 Sep; 122(9):960-5. PubMed ID: 16320503
    [No Abstract]   [Full Text] [Related]  

  • 11. Consequence of therapy discontinuation in bisphosphonate-associated osteonecrosis of the jaws.
    Gallego L; Junquera L
    Br J Oral Maxillofac Surg; 2009 Jan; 47(1):67-8. PubMed ID: 18639371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate-induced osteonecrosis of the jaw 32 months after interruption of zoledronate in a patient with multiple myeloma.
    Del Conte A; Bernardeschi P; La Ferla F; Turrisi G; D'Alessandro M; Montagnani F; Fiorentini G
    J Oral Maxillofac Surg; 2010 May; 68(5):1179-82. PubMed ID: 20185222
    [No Abstract]   [Full Text] [Related]  

  • 13. Bisphosphonate-associated osteonecrosis of the jaw: the rheumatologist's role.
    Capsoni F; Longhi M; Weinstein R
    Arthritis Res Ther; 2006; 8(5):219. PubMed ID: 17049069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orofacial pain - a presenting symptom of bisphosphonate associated osteonecrosis of the jaws.
    Srinivasan D; Shetty S; Ashworth D; Grew N; Millar B
    Br Dent J; 2007 Jul; 203(2):91-2. PubMed ID: 17660779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report.
    Narongroeknawin P; Danila MI; Humphreys LG; Barasch A; Curtis JR
    Spec Care Dentist; 2010; 30(2):77-82. PubMed ID: 20415805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Maxillary osteonecrosis associated with bisphosphonates].
    Madrid C
    Rev Med Suisse; 2006 Nov; 2(86):2575-6. PubMed ID: 17168049
    [No Abstract]   [Full Text] [Related]  

  • 17. Bisphosphonate-associated osteonecrosis. A clinician's reference to patient management.
    Grewal VS; Fayans EP
    N Y State Dent J; 2008 Jan; 74(1):38-44. PubMed ID: 18402375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of osteonecrosis of the jaws and bisphosphonate pharmacotherapy: dental implications.
    Hay KD; Bishop PA
    N Z Dent J; 2006 Mar; 102(1):4-9. PubMed ID: 16568881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteonecrosis of the maxilla in a patient with a history of bisphosphonate therapy.
    Melo MD; Obeid G
    J Can Dent Assoc; 2005 Feb; 71(2):111-3. PubMed ID: 15691429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate-related osteonecrosis of the jaws: a review of 34 cases and evaluation of risk.
    Kos M; Kuebler JF; Luczak K; Engelke W
    J Craniomaxillofac Surg; 2010 Jun; 38(4):255-9. PubMed ID: 19592261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.